Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuromyelitis optica spectrum disorders: Features of aquaporin-4, myelin oligodendrocyte glycoprotein and double-seronegative-mediated subtypes
C. Alves Do Rego, Nicolas Collongues
Revue Neurologique (2018) Vol. 174, Iss. 6, pp. 458-470
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Epstein-Barr Virus and Multiple Sclerosis
Gunnar Houen, Nicole Hartwig Trier, Jette Lautrup Frederiksen
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 78
Pharmacotherapy for Neuromyelitis Optica Spectrum Disorders: Current Management and Future Options
Nicolas Collongues, Estelle Ayme‐Dietrich, Laurent Monassier, et al.
Drugs (2019) Vol. 79, Iss. 2, pp. 125-142
Open Access | Times Cited: 57
Pregnancy in Patients With AQP4-Ab, MOG-Ab, or Double-Negative Neuromyelitis Optica Disorder
Nicolas Collongues, C. Alves Do Rego, Bertrand Bourre, et al.
Neurology (2021) Vol. 96, Iss. 15
Closed Access | Times Cited: 28
Analysis of changes in the chemokine CXC ligand 13 in serum and cerebrospinal fluid of patients with neuromyelitis optica
Juan Zhou, Shalin Luo, Xiaoxi Yao, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Comparison of clinical features of aquaporin-4 positive neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein associated disorder (MOGAD), and double seronegative NMOSD - A single center experience
Melike Çakan, Ezgi Demirel Ozbek, Barışcan Çimen, et al.
Journal of Neuroimmunology (2025), pp. 578591-578591
Closed Access
Diagnostic value of bright spotty lesions on MRI after a first episode of acute myelopathy
Sylvain Rabasté, Álvaro Cobo‐Calvo, Veronica Nistiriuc-Muntean, et al.
Journal of Neuroradiology (2020) Vol. 48, Iss. 1, pp. 28-36
Open Access | Times Cited: 31
Neuromyelitis Optica Spectrum Disorder Treatment—Current and Future Prospects
Marta Waliszewska‐Prosół, Justyna Chojdak-Łukasiewicz, Sławomir Budrewićz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2801-2801
Open Access | Times Cited: 25
Real-life study to assess effectiveness and safety of eculizumab in patients with neuromyelitis optica spectrum disorders in France: protocol for ECUP4, an observational study
Romain Marignier, David Laplaud, Hélène Zéphir, et al.
Frontiers in Neurology (2024) Vol. 14
Open Access | Times Cited: 2
Double seropositive neuromyelitis optica associated with COVID-19: A case report
Dana Antonescu Ghelmez, Adriana Moraru, Florian Antonescu, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 10
The Prevalence, Demographics, Clinical Features, Neuroimaging, and Inter-ethnic Differences of MOGAD in Malaysia with Global Perspectives
ZM Ong, M Arip, YM Ching, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 67, pp. 104168-104168
Closed Access | Times Cited: 9
Plant and human aquaporins: pathogenesis from gut to brain
Jama Lambert, S Rebeca Mejía, Aristo Vojdani
Immunologic Research (2018) Vol. 67, Iss. 1, pp. 12-20
Open Access | Times Cited: 14
Retinal optical coherence tomography and magnetic resonance imaging in neuromyelitis optica spectrum disorders and MOG-antibody associated disorders: an updated review
Ting‐Yi Lin, Claudia Chien, Angelo Lu, et al.
Expert Review of Neurotherapeutics (2021) Vol. 21, Iss. 10, pp. 1101-1123
Closed Access | Times Cited: 11
Understanding Pediatric Neuroimmune Disorder Conflicts: A Neuroradiologic Approach in the Molecular Era
Andrés Server, Tomas Sakinis, Helle Cecilie Viekilde Pfeiffer, et al.
Radiographics (2020) Vol. 40, Iss. 5, pp. 1395-1411
Closed Access | Times Cited: 11
Rapid Discrimination of Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis Using Machine Learning on Infrared Spectra of Sera
Youssef El Khoury, Marie Gébelin, de Sèze, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2791-2791
Open Access | Times Cited: 7
Therapeutic Plasma Exchange in Neuromyelitis Optica Spectrum Disorders and Related Disorders in Resource‐Limited Settings: Outcomes in a Multiethnic Single‐Center Population
Zhi Miin Ong, Jie Ping Schee, Shanthi Viswanathan
Therapeutic Apheresis and Dialysis (2019) Vol. 24, Iss. 3, pp. 312-323
Closed Access | Times Cited: 10
Monoclonal Antibody-Based Treatments for Neuromyelitis Optica Spectrum Disorders: From Bench to Bedside
Wenli Zhu, Yaling Zhang, Zhen Wang, et al.
Neuroscience Bulletin (2020) Vol. 36, Iss. 10, pp. 1213-1224
Open Access | Times Cited: 9
Overcoming the challenges in diagnosis of AQP4-IgG positive neuromyelitis optica spectrum disorders in resource poor settings using an indigenized and cost effective cell based assay
Lekha Pandit, Chaithra Malli, Anitha D′Cunha, et al.
Journal of Neuroimmunology (2021) Vol. 360, pp. 577706-577706
Closed Access | Times Cited: 9
Neuromyelitis optica, aquaporin-4 antibodies, and neuroendocrine disorders
Raffaele Iorio, Claudia Papi
Handbook of clinical neurology (2021), pp. 173-186
Closed Access | Times Cited: 8
Biomarkers in Rare Demyelinating Disease of the Central Nervous System
Marina Boziki, Styliani-Aggeliki Sintila, Panagiotis Ioannidis, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8409-8409
Open Access | Times Cited: 7
Application of deep-learning to the seronegative side of the NMO spectrum
Laura Cacciaguerra, Loredana Storelli, Marta Radaelli, et al.
Journal of Neurology (2021) Vol. 269, Iss. 3, pp. 1546-1556
Closed Access | Times Cited: 5
Satralizumab for the Treatment of Neuromyelitis Optica Spectrum Disorders
Yan-Li Gao, Baoqi Zhang, Junyi Yang
Annals of Pharmacotherapy (2020) Vol. 55, Iss. 9, pp. 1167-1171
Open Access | Times Cited: 4
Rituximab Therapy for Double Seronegative Neuromyelitis Optica Spectrum Disease
Jose Carlos D Saballegue, Ma. Luisa Gwenn P Tiongson
Cureus (2024)
Open Access
Imaging of Neuromyelitis Optica Spectrum Disorders
Sheng‐Che Hung
Seminars in Ultrasound CT and MRI (2020) Vol. 41, Iss. 3, pp. 319-331
Closed Access | Times Cited: 2
Le croiseur était coulé
T. Chaara, Laurent Gilardin, H. Nielly, et al.
La Revue de Médecine Interne (2022) Vol. 43, Iss. 5, pp. 328-331
Open Access | Times Cited: 1
Role of serostatus in pediatric neuromyelitis optica spectrum disorders: A nationwide multicentric study
Ismail Solmaz, İbrahim Öncel, Bahadır Konuşkan, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 77, pp. 104847-104847
Closed Access
Page 1 - Next Page

Scroll to top